🔗 Visit the ClinicalTrials.gov page for NCT01367665
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. | Nat Rev Clin Oncol | 2015 | 2.02 |
| 2 | Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial. | Lancet Oncol | 2015 | 1.35 |
| 3 | Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors. | Cancers (Basel) | 2016 | 0.91 |
| 4 | Characteristics and follow-up of postmarketing studies of conditionally authorized medicines in the EU. | Br J Clin Pharmacol | 2016 | 0.91 |
| 5 | Advanced basal cell carcinoma, the hedgehog pathway, and treatment options - role of smoothened inhibitors. | Biologics | 2015 | 0.85 |
| 6 | Hedgehog signaling pathway and its targets for treatment in basal cell carcinoma. | J Exp Pharmacol | 2012 | 0.75 |
| 7 | Investigational agents in metastatic basal cell carcinoma: focus on vismodegib. | J Exp Pharmacol | 2012 | 0.75 |